Mangoceuticals (MGRX) Net Income towards Common Stockholders Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Net Income towards Common Stockholders Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 14.35% |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 405.72% |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 28.66% |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | -71.96% |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 60.80% |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -9.47% |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 47.88% |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | -69.40% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -38.67% |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | 27.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.98% |
| Dec 31, 2025 | -193.06% |
| Sep 30, 2025 | -245.02% |
| Jun 30, 2025 | -126.48% |
| Mar 31, 2025 | -116.82% |
| Dec 31, 2024 | 24.13% |
| Sep 30, 2024 | -27.44% |
| Jun 30, 2024 | -4.70% |
| Mar 31, 2024 | 7.55% |